{"id":458447,"date":"2021-03-16T07:49:33","date_gmt":"2021-03-16T11:49:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458447"},"modified":"2021-03-16T07:49:33","modified_gmt":"2021-03-16T11:49:33","slug":"vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/","title":{"rendered":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., March  16, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m5hVtEC3ltzma3J9wzyGrq5uBo1lcJfbNKS7tGHWXUj-IKIqAZ_x8VPQTyskevo5GOplQW9d5kNM-8MTBYiuPMA8GfNS3xy12_2Wh4Uo40c=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">VistaGen Therapeutics<\/a> (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tAfQ4v5k-B-xt3749wraBkghS_4KZa1O3vIZHsBwbTcuHJ78yLf2NCRw49RFXMuc8U9Ef9pipELygbQgNJsC8R5QUtJOMV_mqQ80o4cvLjqL8BTSzBfavY6wGR1Qn_jzsOysqD921jUN6O2omHPn7YchQUlVBG6UNI5mR4iWmjkrO67XI0F1odZybYOXqYdNumYpddMB57UQx_Z5zrVK14601gIBF6OsaCFB31yN8JMNuOLK3YkY7ONgBkmT7Izi7JeDlyLGBrQh7cKyS1halQip0E6eDiWOSJMeusVsh4hwLKxsY9bBMj7JtLzsKuyocDZnS2otnC89jJCXPa0sP8NV-ACGGaaX_vhOeKrqBWo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Shawn Singh, VistaGen\u2019s Chief Executive Officer<\/a>, will participate in the following investor conferences in March:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: middle\">\n            <strong><br \/>\n              <u>Maxim Group and M-Vest\u2019s Inaugural Emerging Growth Virtual Conference<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Dates:<\/strong>\n          <\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">March 17<sup>th<\/sup> \u2013 19<sup>th<\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Format:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Corporate Presentation &amp; One-on-One Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>\u00a0<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Friday, March 19<sup>th<\/sup> at 1:00 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Format:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Fireside Chat with Jason McCarthy, Research Analyst<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Website:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">To attend the virtual conference, register <a href=\"https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>\u00a0<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">\n            <a href=\"https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: middle\">\n            <strong><br \/>\n              <u>Benzinga Biotech Small Cap Conference<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Thursday, March 25<sup>th<\/sup> at 10:05 a.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Format:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Corporate Presentation<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>Website:<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">To attend the virtual conference, register <a href=\"https:\/\/www.benzinga.com\/events\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: middle\">\n            <strong>\u00a0<\/strong>\n          <\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">\n            <a href=\"https:\/\/events.benzinga.com\/registration-page16068526119171607978331877\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/events.benzinga.com\/registration-page16068526119171607978331877<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>For more information regarding the conferences, please visit the sponsor conference websites.<\/p>\n<p>\n        <strong>About VistaGen<\/strong><br \/>\n        <br \/>VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen&#8217;s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information, please visit www.vistagen.com and connect with VistaGen on Twitter, LinkedIn, and Facebook.<\/p>\n<p>\n        <strong>Company Contact<\/strong><br \/>\n        <br \/>Mark A. McPartland<br \/>VistaGen Therapeutics, Inc.<br \/>Phone: +1 (650) 577-3600<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UTw_40YhU7L4SywTKpXOIoEHNcEqho59BdDd9fRWeTOD2BoRAV6AD58DNqz6Hi7hDfWrVNG5gJXYu710-r9Lzg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@vistagen.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/56ea5117-7636-41b8-8bb1-8794cdc1ff49\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that Shawn Singh, VistaGen\u2019s Chief Executive Officer, will participate in the following investor conferences in March: Maxim Group and M-Vest\u2019s Inaugural Emerging Growth Virtual Conference Dates: March 17th \u2013 19th Format: Corporate Presentation &amp; One-on-One Fireside Chat \u00a0 \u00a0 Date: Friday, March 19th at 1:00 p.m. ET Format: Fireside Chat with Jason McCarthy, Research Analyst Website: To attend the virtual conference, register here \u00a0 https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference Benzinga Biotech Small Cap Conference &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458447","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that Shawn Singh, VistaGen\u2019s Chief Executive Officer, will participate in the following investor conferences in March: Maxim Group and M-Vest\u2019s Inaugural Emerging Growth Virtual Conference Dates: March 17th \u2013 19th Format: Corporate Presentation &amp; One-on-One Fireside Chat \u00a0 \u00a0 Date: Friday, March 19th at 1:00 p.m. ET Format: Fireside Chat with Jason McCarthy, Research Analyst Website: To attend the virtual conference, register here \u00a0 https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference Benzinga Biotech Small Cap Conference &hellip; Continue reading &quot;VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T11:49:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March\",\"datePublished\":\"2021-03-16T11:49:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/\"},\"wordCount\":261,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/\",\"name\":\"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\",\"datePublished\":\"2021-03-16T11:49:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/","og_locale":"en_US","og_type":"article","og_title":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that Shawn Singh, VistaGen\u2019s Chief Executive Officer, will participate in the following investor conferences in March: Maxim Group and M-Vest\u2019s Inaugural Emerging Growth Virtual Conference Dates: March 17th \u2013 19th Format: Corporate Presentation &amp; One-on-One Fireside Chat \u00a0 \u00a0 Date: Friday, March 19th at 1:00 p.m. ET Format: Fireside Chat with Jason McCarthy, Research Analyst Website: To attend the virtual conference, register here \u00a0 https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference Benzinga Biotech Small Cap Conference &hellip; Continue reading \"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T11:49:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March","datePublished":"2021-03-16T11:49:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/"},"wordCount":261,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/","name":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=","datePublished":"2021-03-16T11:49:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDg5NCM0MDY2NTE2IzIyMDQzODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-upcoming-investor-conferences-in-march\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458447"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458447\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}